Quantitation of reduced IL-33 levels in human serum: Mitigating interference from endogenous binding partners
Aim: IL-33 is a potential therapeutic target but commercially available assays for the quantitation of systemic IL-33 have poor reliability. Results: In commercial IL-33 kits, interference from endogenous binding partners (e.g., soluble ST2) causes under-quantitation. Mitigating this required acid d...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Future Medicine Ltd.
2021
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |